November 28, 2022 01:50 PM ESTUpdated 02:12 PM
Pharma
Manufacturing

FDA tells Catal­ent to fix is­sues at two man­u­fac­tur­ing sites on its own

Tyler Patchen

News Reporter

The CD­MO Catal­ent will have to fix is­sues at two man­u­fac­tur­ing plants in the US and Eu­rope that were sub­ject to in­spec­tions by the FDA …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

No­vo Nordisk claims late-stage MASH vic­to­ry, con­tin­u­ing GLP-1's ex­pan­sion

Bio­gen brings in med­ical chief as CFO plans re­tire­ment; Macro­Gen­ics CEO an­nounces de­par­ture

Ex­clu­sive: Blood stem cell ther­a­py mak­er Garu­da gets new CEO, adds $47M

FDA re­moves hold on three CARs­gen CAR-T tri­als; Ono pass­es on itolizum­ab

Ex­clu­sive: Women’s health uni­corn Maven Clin­ic cuts 10% of its work­force weeks af­ter rais­ing $125M

Bax­ter pulls IV prod­ucts out of Chi­na to shift sup­ply to the US

A service from the Financial Times